Akciğer kanseri: birinci basamakta tanı, tedavi ve korunma

1. Fidaner C, Eser SY, Parkin DM. Incidence in Izmir
in 1993-1994: first results from Izmir Cancer
Registry. Eur J Cancer 2001; 37:83-92.
2. Halilçolar H, Tatar D, Ertuğrul G, Çakan A, Acıtaş
MG, Kömürcüoğlu B. Epidemiyoloji. In: Akkoçlu A,
Öztürk C; eds. Akciğer kanseri multidisipliner yaklaşım.
Toraks Kitapları, Ankara: Bilimsel Tıp Yayınevi;
1999:17-22.
3. Spiro SG, Porter JC. Lung cancer-Where are we
today? Current advances in staging and nonsurgical
treatment. Am J Respir Crit Care Med 2002;
166:1166-1196.
4. Radzikowska E, Raszkowski K, Glaz P. Lung cancer
in patients under 50 years old. Lung Cancer 2001;
33:203-211.
5. Collins LG, Haines C, Perkel R, Enck RE. Lung
cancer: diagnosis and management. Am Fam
Physician 2007; 75(1):56-63.
6. Bilello KS, Murin S, Matthay RA. Epidemiology,
etiology, and prevention of lung cancer. Clin Chest
Med 2002; 23:1-25.
7. İtil O. Akciğer kanserlerinin epidemiyolojisi ve
etyolojisi. In: Haydaroğlu A; ed. Akciğer kanserleri:
Tanı ve tedavi. İzmir:Ege Üniversitesi Basımevi;
2000:15-34.
8. Omenn GS, Merchant J, Boatmann E, Dement JM,
Kuschner M, Nicholson W, et al. Contribution of
environmental fibers to respiratory cancer. Environ
Health Perspect 1986; 70:51-56.
9. Altuntaş HD, Öztürk F, Yılmaz Sİ, Eröz R. Asbest ve
erionite bağlı mezotelyomalı hastaların parafin bloklarında
p53 tümör supressör ve ras onkogen mutasyonlarının
araştırılması. Erciyes Tıp Dergisi 2009;
31(1):1-8.
10. Radzikowska E, Raszkowski K, Glaz P. Lung cancer
in patients under 50 years old. Lung Cancer 2001;
33:203-211.
11. Janerich DT, Thompson WD, Varela LR, Greenwald
P, Chorost S, Tucci C, et al. Lung cancer and
exposure to tobacco smoke in the household. N Engl
J Med 1990; 323(10):632-636.
12. Fraumeni JF Jr. Respiratory carcinogenesis: an
epidemiologic appraisal. J Natl Cancer Inst 1975;
55(5):1039-1046.
13. Bilgel N. Akciğer kanserlerinin epidemiyolojisi. In:
Engin K, Ozyardımcı N; eds. 6. Uludağ Onkoloji
Sempozyumu Kitabı ve Konsensus Raporu. Bursa:
Uludağ Universitesi Yayınları; 2001: 35-8.
14. Travis WD, Travis LB, Devesa SS. Lung cancer.
Cancer 1995; 75(1 suppl):191-202.
15. Patz EF Jr. Imaging bronchogenic carcinoma. Chest
2000; 117(4 suppl 1):90-5.
16. Midthun DE, Jett JR. Clinical presentation of lung
cancer. In: Lung Cancer: Principles and Practice.
Philadelphia, Pa.: Lippincott-Raven, 1996:421.
17. Nesbitt JC. Superior vena cava syndrome: surgery
and stents. In: Pass HI, Mitchell JB, Jhonson DH;
eds. Lung cancer principle and practice. Philadelphia:
Lippincott Williams &Wilkins; 2000:1056-70.
18. Shaheen K, Alraies MC. Superior vena cava
syndrome. Cleve Clin J Med 2012; 79(6):410-2.
19. Paulson DL. Carcinomas in the superior pulmonary
sulcus. J Thorac Cardiovasc Surg 1975; 70:1095-
1104.
20. Parissis H, Young V. Treatment of pancoast tumors
from the surgeons prospective: re-appraisal of the
anterior manubrial sternal approach. J Cardiothorac
Surg 2010; 5:102.
21. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial
evaluation of the patient with lung cancer: symptoms,
signs, laboratory tests, and paraneoplastic syndromes.
Chest 2003; 123(1 suppl):97-104.
22. Akciğer kanseri tanı ve tedavi rehberi. Türk Toraks
Dergisi 2006; 7(2):1-35.
23. Cildağ O, Zamani A, Celik P ve ark. Paraneoplastik
sendromlar. In: Akkoclu A, Ozturk C; eds. Toraks
Kitapları. Akciğer kanseri; multidisipliner yaklaşım.
Ankara: Bilimsel Tıp Yayınevi; 1999;1:38-43.
24. Mcloud TC. Imaging techniques for diagnosis and
staging of lung cancer. Clin Chest Med 2002; 23:123-
135.
25. Mcloud TC. Imaging techniques for diagnosis and
staging of lung cancer. Clin Chest Med 2002; 23:123-
135.
26. Dwamena BA. Metastases from NSCLC: Mediastinal
staging in the 1990s-Meta-analytic comparison of
PET and CT. Radiology 1999; 213:530-536.
27. Pauls S, Buck AK, Hohl K, Halter G, Hetzel M,
Blumstein NM, et al. Improved non-invasive Tstaging
in non-small cell lung cancer by integrated 18
F-FDG PET/CT. Nuclearmedizin 2007; 46(1):9-14.
28. Schimmer C, Neukam K, Elert O. Staging of nonsmall
cell lung cancer: clinical value of positron
emission tomography and mediastinoscopy. Interact
CardioVasc Thorac Surg 2006; 5:418-423.
29. Almeida FA. Bronchoscopy and endobronchial
ultrasound for diagnosis and staging of lung cancer.
Cleve Clin J Med 2012; 79(1):11-16.
30. Dahlstrom JE, Langdale-Smith GM, James DT. Fine
needle aspiration cytology of pulmonary lesions: a
reliable diagnostic test. Pathology 2001; 33:13-16.
31. Hurtgen M, Friedel G, Toomes H, Fritz P. Radical
video-assisted mediastinoscopic lymphadenectomy
(VAMLA)-technique and first results. Eur J
Cardiothorac Surg 2002; 21:348-351.
32. Menzies R, Charbonneau M. Thoracoscopy for the
diagnosis of pleural disease. Ann Intern Med 1991;
114:271-276.
33. Redina EA, Venuta F, De Giacomo T. Comparative
merits of thoracoscopy, mediastinoscopy and
mediastinotomy for mediastinal biopsy. Ann Thorac
Surg 1994; 57:992-995.
34. Murthy S. Video assisted thoracoscopic surgery for
the treatment of lung cancer. Cleve Clin J Med 2012;
79(1):23-25.
35. Papiashvilli M, Stav D, Cyjon A, Haitov Z, Gofman
V, Bar I. Lobectomy for non-small cell lung cancer:
differences in morbidity and mortality between
thoracotomy and thoracoscopy. Innovations (Phila)
2012;7(1):15-22.
36. UICC International Union Against Cancer. TNM
Classification of Malignant Tumors. 6th ed. New
York: Wiley-Liss; 2002.
37. Goldstraw P, Crowley J, Chansky K, Giroux DJ,
Groome PA, Rami-Porta R, et al. The IASLC Lung
Cancer Staging Project: Proposals for the revision of
the TNM Stage Groupings in the Forthcoming
(Seventh) Edition of the TNM Classification of
Malignant Tomours. J Thorac Oncol. 2007; 2:706-
714.
38. Detterbeck FC, Boffa DJ, Tanoue LT. The new lun
cancer staging system. Chest 2009; 136(1):260-271.
39. Boffa DJ, Allen MS, Grab JD, et al. Data from The
Society of Thoracic Surgeons General Thoracic
Surgery database: the surgical management of
primary lung tumors. J Thorac Cardiovasc Sur. 2008;
135(2):247-254.
40. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J,
Minna J. Randomized trail of neoadjuvant therapy for
lung cancer: Interim analysis. Ann Thorac Surg 1992;
53(6):992-998.
41. Roth JA, Atkinson EN, Fosella F, Komaki R,
Bernadette Ryan M, Putnam JB Jr, et al. Long term
follow-up of patients enrolled in a randomized trial
comparing perioperative chemotherapy and surgery
with surgery alone in resectable stage IIIA non-small
cell lung cancer. Lung Cancer 1998; 21:1-6.
42. Douillard JY, Rosell R, De Lena M, Carpagnano F,
Ramlau R, Gonzales-Larriba JL, et al. Adjuvant
vinorelbine plus cisplatin versus observation in
patients with completely resected stage IB-IIIA nonsmall-
cell lung cancer (Adjuvant Navelbine
International Trialist AssociationANITA): a
randomised controlled trial. Lancet Oncol 2006;
7(9):719-727.
43. Akciğer kanseri tanı-tedavi-takip. Antakya
konsensusu. In: Aydıner A, Ece T, Topuz E; eds. İstanbul:
Nobel Tıp Kitapevleri; 2010:61.
44. Akciğer kanseri tanı ve tedavi rehberi. Türk Toraks
Dergisi 2006; 7(2):1-35.
45. IchinosaY. Counterpoint. In: Johnson FE, Virgon KS;
eds. Cancer patient follow-up. St.Louis: MO:Mosby;
1997: 230-232.
46. Walsh GL, O’Connor M, Willis KM, Milas M, Wong
RS, Nesbitt JC, et al. Is follow –up of lung cancer
patients after resection medically indicated and
costeffective? Ann Thorac Surg 1995; 60(6):1563-
1572.
47. Senn HJ. Supportive and palliative care in cancer
patients. 21st ESMO Congress, Vienna, Austria,
November 1-5, 1996.
48. Humphrey LL, Teutsch S, Johnson M, fort he U.S.
Preventive Services Task Force. Lung cancer
screening with sputum cytologic examination, chest
radiography, and computed tomography: an update
fort he U.S. Preventive Services Task Force. Ann
Intern Med 2004; 140:740-753.
49. U.S. Preventive Services Task Force. Lung cancer
screening: recommedation statement. Ann Intern
Med 2004; 140:738-739.
50. Manser RL, Irving LB, Stone C, Byrnes G,
Abramson M, Campbell D. Screening for lung
cancer. Cochrane Database Syst Rev 2004;
(1):CD001991.
İletişim:
Doç.Dr. Erkan Melih Şahin
Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi
Aile Hekimliği Anabilim Dalı
Terzioğlu Yerleşkesi, Çanakkale, Türkiye
Tel: +90.286.2180018 (2208)
e-mail:emsahin@yahoo.com